Science Explorer Interactive view Map
Company · Sandvika · Norway

AlgiPharma (Norway)

algipharma.com/en/en/home.aspxROR OpenAlex
Research works
14
▼ 27% vs 2013–17
Citations
336
24.6 per fractional work
Top-10% rate
9.0%
record average 16.5%
Open access
71%
world 28%

Not ranked overall: AlgiPharma (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 4.22× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.91× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 43.74× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.84× its world share, 0 worksChemistryHealth Professions: 4.39× its world share, 0 worksHealth ProfessionsMedicine: 1.04× its world share, 0 worksMedicineNursing: 7.87× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 43.7×. Every wedge is a field page.

Which research topics does AlgiPharma (Norway) publish most on?

By volume in 2022–2025: Advanced Drug Delivery Systems, Cystic Fibrosis Research Advances, Dysphagia Assessment and Management and Probiotics and Fermented Foods.

Advanced Drug Delivery S…0Advanced Drug Delivery Systems: 0 fractional worksCystic Fibrosis Research…0Cystic Fibrosis Research Advances: 0 fractional worksDysphagia Assessment and…0Dysphagia Assessment and Management: 0 fractional worksProbiotics and Fermented…0Probiotics and Fermented Foods: 0 fractional worksBacterial biofilms and quorum sensing: 0 fractional worksSeaweed-derived Bioactive Compounds: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksHydrogels: synthesis, properties, applications: 0 fractional worksMedicinal Plants and Neuroprotection: 0 fractional worksAntibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional works
Pharmaceutical SciencePulmonary and Respiratory MedicineSpeech and HearingFood Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  2. 2 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  3. 3 Dysphagia Assessment and Management Speech and Hearing 0 works
  4. 4 Probiotics and Fermented Foods Food Science 0 works
  5. 5 Bacterial biofilms and quorum sensing Molecular Biology 0 works
  6. 6 Seaweed-derived Bioactive Compounds Aquatic Science 0 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 0 works
  8. 8 Hydrogels: synthesis, properties, applications Molecular Medicine 0 works
  9. 9 Medicinal Plants and Neuroprotection Complementary and alternative medicine 0 works
  10. 10 Antibiotic Resistance in Bacteria Molecular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.4%not open28.6%

World: 28% of research is openly available.

with international co-authors73.2%domestic only26.8%

World: 19% is written across borders.

How has AlgiPharma (Norway)'s research output changed?

Output in 2018–2022 was 27% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Sandvika

All research institutions in Sandvika

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.